april-phantan-angkool-md

April Phantana-angkool, MD

Breast Surgery
Accepting New Patients
(425) 635-3400
Offers Virtual Visits | A quick, convenient way to see your provider. Call the clinic to schedule.
Specialties
  • Breast Surgery
Clinical Interests
  • Benign and malignant disease
  • Breast conservation surgery
  • Nipple and skin sparing mastectomy
  • Sentinel lymph node biopsy
  • Oncoplastic surgery
  • Evaluation and treatment of hereditary breast cancer
Languages
  • English
  • Thai
Board Certification
American Board of Surgery
Philosophy of Care

Every patient is unique. I believe that the best approach to the diagnosis of breast cancer is a collaborative partnership with a patient and all available breast cancer specialties to achieve a compassionate and individualized treatment plan. Through honest discussion and tailored education, I hope to help empower my patients in all aspects of their medical care to help achieve their personal goals.

Get to Know Me

My husband and I love taking advantage of the beauty of the Pacific Northwest through hiking, running and skiing with our friends and family. I also love cooking, exploring the delicious variety of cuisines in the area as well as traveling.

Medical School
University of Alabama Medical Center
Birmingham, AL
2009
Internship
Baptist Health System
Birmingham, AL
2010
Fellowship
Carolinas Medical Center - Levine Cancer Institute, Breast Surgical Oncology
Charlotte, NC
2018
Residency
Baptist Health System
Birmingham, AL
2015
Professional Memberships
Society of Surgical Oncology
American Society of Breast Surgeons
American College of Surgeons
Publications
Breast Cancer Research and Treatment.
Rate of radial scars by core biopsy and upgrading to malignancy or high-risk lesions before and after introduction of digital breast tomosynthesis.
2019 Jan;173(1):23-29.
Phantana-angkool A, Forster MR Warren YE, Livasy CA, Sobel AH, Beasley LM, Trufan SJ, Hadzikadic-Gusic L, Sarantou T, Voci AE, Sarma D, White RL Jr.
Annals of Surgical Oncology.
Ductal carcinoma in situ with microinvasion on core biopsy: evaluating tumor upstaging rate, lymph node metastasis rate, and associated predictive variables.
2019 Nov;26(12):3874-3882.
Phantana-angkool A, Voci AE, Warren YE, Livasy CA, Beasley LM, Robinson MM, Hadzikadic-Gusic L, Sarantou T, Forster MR, Sarma D, White RL Jr.

Locations